| Dr Royal J Eaton, MD | |
|
11133 Dunn Rd, Suite 2335, Saint Louis, MO 63136-6119 | |
| (314) 653-5007 | |
| (314) 653-4149 |
| Full Name | Dr Royal J Eaton |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 11133 Dunn Rd, Saint Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780675264 | NPI | - | NPPES |
| 200333805 | Medicaid | MO | |
| CE7661 | Other | MO | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | MO30472 (Missouri) | Primary |
| Entity Name | Pulmonary Consultants,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164534210 PECOS PAC ID: 1355317280 Enrollment ID: O20081210000646 |
News Archive
The national commander of The American Legion applauds the Senate for their overwhelming support of the Caregivers and Veterans Omnibus Health Services Act of 2009 with a resounding 98-0 vote yesterday. "This legislation will improve the lives of so many veterans and their families," said National Commander Clarence E. Hill. "Especially those with serious health care challenges."
Duke University could receive up to $19 million to lead early-stage clinical trials for new drugs to treat neurological conditions such as Alzheimer's disease and neuropathy.
Genetic polymorphisms associated with cancer progression lead to variations in gene expression and may serve as prognostic markers for lung cancer. Researchers at the Hiroshima University and Saitama Medical University found that in patients with lung cancer, a single nucleotide polymorphism (SNP) may regulate gene and protein expression and be associated with poor prognosis.
SHIFT Communications, the leader in data-driven public relations and communications, today announced the expansion of its healthcare practice. Since January, SHIFT's healthcare practice has grown its revenue nearly 30 percent and expanded not only the team, but the diversity of the clientele they serve – moving beyond health information technology (IT) to sectors ranging from digital health to the life sciences.
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has closed on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited, a top 20 pharmaceutical company, for the development of its novel anti-cancer compound, RX-3117. RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Royal J Eaton, MD 11133 Dunn Rd, Suite 2335, Saint Louis, MO 63136-6119 Ph: (314) 653-5007 | Dr Royal J Eaton, MD 11133 Dunn Rd, Suite 2335, Saint Louis, MO 63136-6119 Ph: (314) 653-5007 |
News Archive
The national commander of The American Legion applauds the Senate for their overwhelming support of the Caregivers and Veterans Omnibus Health Services Act of 2009 with a resounding 98-0 vote yesterday. "This legislation will improve the lives of so many veterans and their families," said National Commander Clarence E. Hill. "Especially those with serious health care challenges."
Duke University could receive up to $19 million to lead early-stage clinical trials for new drugs to treat neurological conditions such as Alzheimer's disease and neuropathy.
Genetic polymorphisms associated with cancer progression lead to variations in gene expression and may serve as prognostic markers for lung cancer. Researchers at the Hiroshima University and Saitama Medical University found that in patients with lung cancer, a single nucleotide polymorphism (SNP) may regulate gene and protein expression and be associated with poor prognosis.
SHIFT Communications, the leader in data-driven public relations and communications, today announced the expansion of its healthcare practice. Since January, SHIFT's healthcare practice has grown its revenue nearly 30 percent and expanded not only the team, but the diversity of the clientele they serve – moving beyond health information technology (IT) to sectors ranging from digital health to the life sciences.
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has closed on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited, a top 20 pharmaceutical company, for the development of its novel anti-cancer compound, RX-3117. RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.
› Verified 3 days ago
Dr. Isik Turker, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 4921 Parkview Pl, Div Im Cardiology, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-1291 Fax: 314-362-4278 | |
Conor Mccartney, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 915 N Grand Blvd, Saint Louis, MO 63106 Phone: 314-652-4100 | |
Dr. Faris Adam Bakeer, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Rehan Rais, M.D. M.B.,B.S. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 660 S Euclid Ave, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Nathan Farkas, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-1930 | |
Dr. Nicole Foley, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Soumojit Ghosh, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista Ave, Saint Louis, MO 63110 Phone: 314-977-6100 Fax: 314-977-6164 |